First-Trimester or Second-Trimester Screening, or Both, for Down's SyndromeFergal D. Malone, Mary E. D’Alton, Jacob A. Canick et al.|New England Journal of Medicine|2005Cited by 1.1k
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEsSimon Eschweiler, Christian H. Ottensmeier, Ciro Ramírez-Suástegui et al.|Nature|2022Cited by 91
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAlona Zer, Frances A. Shepherd, Lei Han et al.|Journal of Thoracic Oncology|2015Cited by 55
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Andrew Creamer, Priyam Verghese et al.|The Lancet Oncology|2025Cited by 48
The reporting of pulmonary nodule results by letter in a lung cancer screening settingJennifer Dickson, Sam M. Janes, Amyn Bhamani et al.|Lung Cancer|2022Cited by 13